PROCLAIM_2B: PROCLAIM, figure 2B

PROCLAIM_2BR Documentation

PROCLAIM, figure 2B

Description

Kaplan-Meier digitized data from PROCLAIM, figure 2B (PMID 26811519). A reported sample size of 598 for a primary endpoint of OS in lung cancer.

Usage

PROCLAIM_2B

Format

A data frame of 598 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (eto_cis, pem_cis)

Source

Senan S, Brade A, Wang L-H, et al. PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer. J Clin Oncol 2016; 34: 953–62.

Examples

summary(PROCLAIM_2B)

kmplot(PROCLAIM_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.